Document is current
Any future updates will be listed below
-
Authors
Hu, Jiayi
Abulimiti, Yilimunuer
Wang, Haiyang
Yang, Dianyu
Wang, Xu
Wang, Yang
Ji, Ping
-
Funding
Funding for this research was provided by:
Foundation for Innovative Research Groups of the National Natural Science Foundation of China (82002223)
Natural Science Foundation of Shanghai (24ZR1463300)
State Key Laboratory of Neurology and Oncology Drug Development (SKLSIM-2024061)
- License Information
-
More Information
Article History
Received: 24 January 2025
Accepted: 24 April 2025
First Online: 10 May 2025
Declarations
:
: This study draws on published research and publicly available data from various consortia. All original studies included in this analysis have been approved by their respective ethical review committees, and informed consent was obtained from all participants. The use of RT-qPCR and WB, in combination with individual-level data, to verify the expression levels of TXN in cancerous and adjacent tissues, was approved by the Ethics Committee of Shanghai Tongji Hospital (ethics approval number: sbtk-2024-246).
: Not applicable.
: The authors declare no competing interests.
: Not applicable.
